Management of Acute Pyelonephritis in Adults
For outpatient management of uncomplicated pyelonephritis, use oral fluoroquinolones (ciprofloxacin 500-750 mg twice daily for 7 days or levofloxacin 750 mg daily for 5 days) as first-line therapy when local resistance is <10%, or oral cephalosporins (cefpodoxime 200 mg twice daily or ceftibuten 400 mg daily for 10 days) preceded by a single IV dose of ceftriaxone. 1
Initial Diagnostic Approach
Obtain urine culture with antimicrobial susceptibility testing in all cases before initiating antibiotics 1, 2. Urinalysis showing white blood cells, red blood cells, and nitrite supports the diagnosis 1.
Perform upper urinary tract ultrasound immediately if:
- History of urolithiasis
- Renal function disturbances
- High urine pH
- Pregnancy (use ultrasound or MRI only—avoid radiation) 1
Obtain CT scan with contrast or excretory urography if:
- Patient remains febrile after 72 hours of treatment
- Clinical deterioration occurs at any time 1
This imaging distinction is critical because obstructive pyelonephritis can rapidly progress to urosepsis and requires urgent urological intervention 1.
Outpatient Antibiotic Regimens (Uncomplicated Cases)
Only fluoroquinolones and cephalosporins are recommended for oral empiric treatment 1. Avoid nitrofurantoin, oral fosfomycin, and pivmecillinam—insufficient efficacy data 1.
Oral Regimens:
- Ciprofloxacin: 500-750 mg twice daily for 7 days
- Levofloxacin: 750 mg once daily for 5 days
- Trimethoprim-sulfamethoxazole: 160/800 mg twice daily for 14 days (if susceptible)
- Cefpodoxime: 200 mg twice daily for 10 days
- Ceftibuten: 400 mg once daily for 10 days 1
Critical caveat: Fluoroquinolone use requires local resistance <10% 1. When using oral cephalosporins empirically, administer one initial IV dose of long-acting parenteral antibiotic (e.g., ceftriaxone 1-2 g) because oral cephalosporins achieve significantly lower blood and urinary concentrations than IV formulations 1.
Duration consideration: Shorter courses (5-7 days) show equivalent clinical and microbiological success to longer durations but carry higher recurrence rates at 4-6 weeks 1. This trade-off should be tailored to local resistance patterns 1.
Inpatient Antibiotic Regimens (Hospitalized Patients)
Initiate IV therapy with fluoroquinolones, aminoglycosides (with or without ampicillin), or extended-spectrum cephalosporins/penicillins 1.
IV Regimens:
- Ciprofloxacin: 400 mg twice daily
- Levofloxacin: 750 mg once daily
- Ceftriaxone: 1-2 g once daily (higher dose recommended)
- Cefepime: 1-2 g twice daily (higher dose recommended)
- Piperacillin-tazobactam: 2.5-4.5 g three times daily
- Gentamicin: 5 mg/kg once daily
- Amikacin: 15 mg/kg once daily 1
Reserve carbapenems and novel broad-spectrum agents (ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol) exclusively for early culture results showing multidrug-resistant organisms 1. Base all choices on local resistance patterns 1.
Special Populations
Pregnancy
All pregnant patients with pyelonephritis require hospital admission and initial parenteral therapy due to significantly elevated risk of severe complications 2.
- Use ultrasound or MRI exclusively for imaging—avoid radiation exposure 1
- Avoid fluoroquinolones and aminoglycosides
- Preferred agents: IV ceftriaxone or piperacillin-tazobactam
- Consider pregnancy as a complicated UTI requiring extended treatment 1, 3
Renal Impairment
Dose-adjust aminoglycosides and fluoroquinolones based on creatinine clearance. Extended-spectrum cephalosporins (ceftriaxone) require minimal adjustment unless severe impairment exists.
Complicated Pyelonephritis
Complicating factors include: obstruction, foreign body, incomplete voiding, vesicoureteral reflux, recent instrumentation, male sex, pregnancy, diabetes, immunosuppression, healthcare-associated infection, or multidrug-resistant organisms 1.
These patients require broader initial coverage, longer treatment courses, and often specialist consultation (urology, infectious disease) 4.
Follow-Up Care
Repeat urine culture 1-2 weeks after completing antibiotic therapy 5.
Treatment failure indicators:
- Persistent fever beyond 48-72 hours
- Clinical deterioration
- Recurrent symptoms
When treatment fails, immediately:
- Repeat blood and urine cultures
- Obtain imaging (CT with contrast)
- Consider resistant organisms, anatomic/functional abnormalities, or immunosuppression
- Change antibiotics based on susceptibility data
- Consult urology if obstruction or abscess identified 5, 2
Common Pitfalls
Do not use nitrofurantoin, fosfomycin, or pivmecillinam for pyelonephritis—these agents lack adequate tissue penetration and efficacy data 1.
Do not empirically use fluoroquinolones when local E. coli resistance exceeds 10%—this threshold is frequently exceeded in many communities 1, 6, 7.
Do not rely on oral cephalosporins alone without initial IV dosing—their bioavailability is insufficient for reliable empiric coverage 1.
Do not delay imaging in patients with persistent fever, deterioration, or known urological abnormalities—obstructive pyelonephritis requires urgent decompression to prevent urosepsis 1, 2.